As the US restarts war on Iran, is its weapons stockpile running low?

The US has expended at least half of multiple high-end munitions since restarting its Iran campaign on Feb 28, with the 39-day period seeing 13,000+ targets hit using systems including Tomahawk, JASSM, SM-3/SM-6, THAAD and Patriots. CSIS estimates Washington may lack enough for future major wars—especially versus China—because replenishing costly weapons is expected to take 1 to 4 years (e.g., Tomahawk 4–5 years, THAAD 3–3.5 years, Patriot ~3 years). The article also notes Trump’s $1.5 trillion 2027 defense budget (up 44% vs 2026) and the Defense Production Act to accelerate manufacturing, but near-term allied supply capacity and delivery timelines face delays.

Analysis

The market should treat this as a munitions-capacity story, not a headline-driven geopolitics trade. The earnings impact is delayed: the near-term burn benefits only the inventory managers, while the real P&L flow is a multi-quarter backlog build once the Pentagon converts urgency into funded awards. That makes RTX and LMT the cleanest exposures; NOC is more of a secondary beneficiary, and BA is largely a distractor unless the company can prove meaningful missile/air-defense mix shift.

The bigger second-order winner is the supply chain behind the primes: solid rocket motors, energetics, seekers, guidance electronics, and test equipment. If surge demand persists, primes will likely see lower gross margin at first because overtime, sub-tier prepayments, and capacity expansion front-load cash outlays before revenue catches up. That means the best relative performance may come from the most bottlenecked components, while the prime contractors can still outperform on backlog visibility but not necessarily on margin expansion.

Contrarianly, consensus may be underestimating how fast this can fade if there is any credible de-escalation or if Congress balks at a large supplemental. The stockpile concern is structurally bullish for defense over 6-18 months, but the equity tape will care more about whether awards show up by late summer/fall and whether delivery schedules actually tighten. If the 2027 budget request does not translate into firm production orders, this becomes a readiness story, not a stock story.

Key Decisions for Investors

• Overweight RTX vs NOC on a 1-3 month horizon: RTX has the most direct leverage to replenishment of interceptors and missile-defense inventory; NOC is more diluted to the theme. Enter on any post-news pullback; thesis breaks if ceasefire headlines reduce expected burn or if order flow does not inflect by the next budget cycle.
• Initiate a small long LMT / short NOC pair trade into the next defense-budget and supplemental-appropriations headlines. Risk/reward is favorable if the market starts pricing multiyear replenishment, but cut the trade if management commentary indicates production bottlenecks are pushing deliveries out without incremental price.
• Buy 6-12 month call spreads in RTX or LMT rather than outright shares if you want convexity to a replenishment re-rating. The setup is asymmetric because the near-term downside is capped by backlog, while upside depends on a second wave of awards and capacity expansion language.
• Avoid chasing BA as a direct beneficiary; the article’s mechanism is too far from its core earnings engine. BA only becomes interesting if defense-mix commentary shows missile-defense content becoming material, which is not yet visible.